Do Nonsteroidal Antiinflammatory Drugs Lower Risk of Colorectal Cancer?

REFERENCES

• , Cancernet.nci.nih.gov/seer/Colorectal_cancer.html
   Google Scholar
• , Cancernet.nci.nih.gov/wyntk_pubs/colon.htm
   Google Scholar
• Mandel J, Bond J, Church T, et al. Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood. N Engl J Med 1993; 328: 1365–1371
   PubMed Web of Science ®Google Scholar
• Lieberman D, Weiss D, Bond J, et al. Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer. N Engl J Med 2000; 343: 162–168
   PubMed Web of Science ®Google Scholar
• Imperiale T, Wagner D, Lin C, et al. Risk of Advanced Proximal Neoplasms in Asymptomatic Adults According to the Distal Colorectal Findings. N Engl J Med 2000; 343: 169–174
   PubMed Web of Science ®Google Scholar
• , Cancernet.nci.nih.gov
   Google Scholar
• Riethmuller G, Holz E, Schlimok G, et al. Monoclonal Antibody Therapy for Resected Dukes' C Colorectal Cancer: Seven-Year Outcome of a Multicenter Randomized Trial. J Clin Oncology 1998; 16(5)1788–1794
   PubMed Web of Science ®Google Scholar
• Baron J A, Sandler R S. Nonsteroidal Anti-Inflammatory Drugs and Cancer Prevention. Annu Rev Med 2000; 51: 511–523
   PubMed Web of Science ®Google Scholar
• Piazza G, Rahm A, Krutzsch M, et al. Antineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing Apoptosis. Cancer Res 1995; 55: 3110–3116
   PubMed Web of Science ®Google Scholar
• Giardello F M, Hamilton S R, Krush A J, et al. Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis. N Engl J Med 1993; 328: 1313–1316
   PubMedGoogle Scholar
• Pinczowski D, Ekbom A, Baron J, et al. Risk Factors for Colorectal Cancer in Patients with Ulcerative Colitis: A Case-Control Study. Gastroenterology 1994; 107: 117–120
   PubMed Web of Science ®Google Scholar
• Gridley G, McLaughlin J K, Ekbom A, et al. Incidence of Cancer Among Patients with Rheumatoid Arthritis. J Natl Cancer Inst 1993; 85: 307–311
   PubMed Web of Science ®Google Scholar
• Isomaki H A, Hakulinen T, Joutsenlahti U. Excess Risk of Lymphomas, Leukemia and Myeloma in Patients with Rheumatoid Arthritis. J Chron Dis 1978; 31: 691–696
   PubMedGoogle Scholar
• Laakso M, Mutru O, Isomaki H, et al. Cancer Mortality in Patients with Rheumatoid Arthritis. J Rheumatol 1986; 13: 522–526
   PubMed Web of Science ®Google Scholar
• Kune G A, Kune S, Watson L F. Colorectal Cancer Risk, Chronic Illnesses, Operations and Medications: Case Control Results from the Melbourne Colorectal Cancer Study. Cancer Res 1988; 48: 4399–4404
   PubMed Web of Science ®Google Scholar
• Thun M J, Namboodiri M M, Heath C W, Jr. Aspirin Use and Reduced Risk of Fatal Colon Cancer. N Engl J Med 1991; 325: 1593–96
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Palmer J R, Zauber A G, et al. A Hypothesis: Nonsteroidal Anti-Inflammatory Drugs Reduce the Incidence of Large-Bowel Cancer. J Natl Cancer Inst 1991; 83: 355–358
   PubMed Web of Science ®Google Scholar
• Suh O, Mettlin C, Petrelli N J. Aspirin Use, Cancer and Polyps of the Large Bowel. Cancer 1993; 72: 1171–1177
   PubMed Web of Science ®Google Scholar
• Logan R, Little J, Hawtin P, et al. Effect of Aspirin and Non-Steroidal Anti-Inflammatory Drugs on Colorectal Adenomas: Case-Control Study of Subjects Participating in Nottingham Faecal Occult Blood Screening Programme. BMJ 1993; 307: 285–289
   PubMedGoogle Scholar
• Muscat J E, Stellman S D, Wynder E L. Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer. Cancer 1994; 74: 1847–1854
   PubMed Web of Science ®Google Scholar
• Peleg I I, Maibach H T, Brown S H, et al. Aspirin and Non-steroidal Anti-Inflammatory Drug Use and the Risk of Subsequent Colorectal Cancer. Arch Intern Med 1994; 154: 394–399
   PubMedGoogle Scholar
• Collet J P, Sharpe C, Belzile E, et al. Colorectal Cancer Prevention by Non-Steroidal Anti-Inflammatory Drugs: Effects of Dosage and Timing. Br J Cancer 1999; 81(1)62–68
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Louik C, Shapiro S. Nonsteroidal Antiinflammatory Drug Use and Reduced Risk of Large Bowel Carcinoma. Cancer 1998; 82: 2326–2333
   Google Scholar
• Breuer-Katschinski B, Nemes K, Rump B, et al. Long-Term Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Colorectal Adenomas. Digestion 2000; 61: 129–134
   Google Scholar
• Paganini-Hill A, Chao A, Ross R, et al. Aspirin Use and Chronic Disease: A Cohort Study of the Elderly. BMJ 1989; 299: 1247–1250
   PubMed Web of Science ®Google Scholar
• Greenberg E R, Baron J A, Freeman D H, Jr., et al. Reduced Risk of Large-Bowel Adenomas Among Aspirin Users. J Natl Cancer Inst 1993; 85: 912–916
   PubMedGoogle Scholar
• Thun M J, Namboodiri M M, Calle E E, et al. Aspirin Use and Risk of Fatal Cancer. Cancer Res 1993; 53: 1322–1327
   PubMed Web of Science ®Google Scholar
• Schreinemachers D M, Everson R B. Aspirin Use and Lung, Colon and Breast Cancer Incidence in a Prospective Study. Epidemiology 1994; 5: 138–146
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Rimm E B, Stmpfer M J, et al. Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals. Ann Intern Med 1994; 121: 241–246
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Egan K M, Hunter D J. Aspirin and the Risk of Colorectal Cancer in Women. N Engl J Med 1995; 333: 609–614
   PubMed Web of Science ®Google Scholar
• Gann P H, Manson J E, Glynn R J, et al. Low-Dose Aspirin and Incidence of Colorectal Tumors in a Randomized Trial. J Natl Cancer Inst 1993; 85: 1220–1224
   PubMed Web of Science ®Google Scholar
• Sturmer T, Glynn R J, Lee I M, et al. Aspirin Use and Colorectal Cancer: Post-Trial Follow-Up Data from the Physicians' Health Study. Ann Intern Med 1998; 128: 713–720
   PubMed Web of Science ®Google Scholar